(ARWR) Arrowhead Pharmaceuticals Renko charts technical analysis
(ARWR) Arrowhead Pharmaceuticals Renko charts technical analysis Renko analysis of Arrowhead Pharmaceuticals | Buy/Sell Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Arrowhead Pharmaceuticals is 2481811
Date | Closing Price | Open | High | Low | Volume |
25 Fri Jul 2025 | 15.74 | 16.12 | 16.31 | 15.62 | 1.766 Mn |
24 Thu Jul 2025 | 16.26 | 15.92 | 16.52 | 15.65 | 2.449 Mn |
23 Wed Jul 2025 | 15.92 | 15.42 | 16.62 | 15.14 | 3.419 Mn |
22 Tue Jul 2025 | 14.96 | 14.65 | 15.04 | 14.30 | 2.729 Mn |
21 Mon Jul 2025 | 14.71 | 16.96 | 17.00 | 14.32 | 6.746 Mn |
18 Fri Jul 2025 | 16.76 | 19.05 | 19.33 | 16.67 | 3.012 Mn |
17 Thu Jul 2025 | 18.79 | 18.35 | 19.04 | 18.10 | 0.909 Mn |
16 Wed Jul 2025 | 18.30 | 17.87 | 18.43 | 17.75 | 1.248 Mn |
15 Tue Jul 2025 | 17.63 | 18.79 | 18.91 | 17.59 | 1.459 Mn |
14 Mon Jul 2025 | 18.61 | 18.17 | 19.06 | 18.17 | 1.4 Mn |
Indicators analysis of Arrowhead Pharmaceuticals (ARWR)
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term but the sell signal is initial and weak.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.08 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term but the sell signal is initial and weak.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.08 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.